B Elgohari, P P Patwardhan, M K Abdelhakiem, R Bhargava, P Sukumvanich, M Courtney-Brooks, M M Boisen, J L Berger, S Taylor, A Olawaiye, J Lesnock, R P Edwards, S Beriwal, T R Soong, J A A Vargo
PURPOSE/OBJECTIVE(S): Vulvar cancer is a rare female genital neoplasm in which surgery and radiotherapy play an integral role in the treatment paradigm; however, locoregional recurrence remains the predominant pattern of failure. Little is known about the impact of PD-L1 status in vulvar cancer and its value for clinical outcomes and response prediction to immunotherapy. We sought to explore clinical outcomes of patients with positive PD-L1 expression in vulvar cancer. MATERIALS/METHODS: Single-institution retrospective analysis of patients with surgically resectable invasive vulvar carcinoma from 2001-2021 was performed...
October 1, 2023: International Journal of Radiation Oncology, Biology, Physics